Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) - ONA
Links shared publicly online about this topic.
- 672total visits
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) - ONA
Spectrum Pharmaceuticals announced results from both a Phase 2 and Phase 3 study of Zevalin (ibritumomab tiuxetan) injection for the treatment of follicular non-Hodgkin's lymphoma (NHL).
View full resource at oncologynurseadvisor.com
Tags: Cancer, Lymphoma, Non-Hodgkin Lymphoma, Pharma, Phase 3 Clinical Trial
Most Recently Shared on December 7, 2010 at 8:49 pm By:
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) http://goo.gl/fb/I2Tif
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) - MPR
empr.com — “Spectrum Pharmaceuticals announced results from both a Phase 2 and Phase 3 study of Zevalin (ibritumomab tiuxetan) injection for the treatment of follicular non-Hodgkin's lymphoma (NHL).” View full resource at empr.com
Most Recently Shared on December 7, 2010 at 9:12 pm By:
MPR News: Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL): Spectrum Pharmaceu... http://bit.ly/hPNeyO
Advertisement
